Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

By afschroeder • April 7, 2026

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE Endocrinol Diabetes. 2025 Nov 13;13(2):303-307. doi: 10.1016/j.aed.2025.11.001. PMID: 41938296; PMCID: PMC13043445.

Tags: Endocrinology, hypertensive crisis, lutetium-177 DOTATATE, metastatic pheochromocytoma, metyrosine, peptide receptor radionuclide therapy, Publications

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center

Tavares M, Khoshbin K, Solorzano W, Scarlett L, Santana C, Lopez R, Villanueva GP, Escobar B, Mangual KS, Pavlish C, Bush NJ, Moin T, Everett[...]

Enhancing mental and physical health of women through engagement and retention (EMPOWER) 3.0 QUERI: study protocol for a cluster-randomized hybrid type 3 implementation-effectiveness trial

Hamilton AB, Farmer MM, Bean-Mayberry B, Moin T, Lang A, Adams L, Chanfreau C, Fenwick K, Canelo I, Oberman R, Finley EP; EMPOWER 3.0 QUERI[...]

Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets

Acin-Perez R, Assali EA, Veliova M, Ngo J, Brownstein AJ, Villalobos F, Petcherski A, Hernansanz-Agustin P, Kim-Vasquez D, Xu S, Tamboline M, Silva RM, Upcher[...]